Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

Aim: Intravesical Bacillus Calmette–Guérin (BCG) is the standard therapy for non-muscle invasive bladder cancer (NMIBC); however, many patients experience recurrence or progression. We examined how urinary immune signals and the urinary microbiome change across BCG and are related to outcomes. Metho...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Yuki Oda, Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, Takuya Owari, Kota Iida, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Open Exploration Publishing Inc. 2026-04-01
سلاسل:	Exploration of Targeted Anti-tumor Therapy
الموضوعات:	bacillus calmette–guérin (bcg) therapy non-muscle invasive bladder cancer urinary immune profiling urinary microbiome dynamics firmicutes/bacteroidetes ratio progression-free survival
الوصول للمادة أونلاين:	https://www.explorationpub.com/uploads/Article/A1002365/1002365.pdf
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!